Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

INTERRELATIONS AMONG PATTERNS OF CHANGE IN NEUROCOGNITIVE, CT BRAIN IMAGING AND CD4 MEASURES ASSOCIATED WITH ANTIRETROVIRAL THERAPY IN CHILDREN WITH SYMPTOMATIC HIV-INFECTION ADVANCES IN NEUROIMMUNOLOGY Brouwers, P., Decarli, C., TUDORWILLIAMS, G., Civitello, L., Moss, H., Pizzo, P. 1994; 4 (3): 223-231

Abstract

The interrelationships of patterns of change and variability between baseline and after 6 months of anti-retroviral therapy in neurocognitive, brain imaging, and immune measures were studied in 77 children with symptomatic HIV disease. Overall improvement in CNS structure/function after 6 months of anti-retroviral therapy was limited; new intracerebral calcifications tended to occur and old ones tended to progress in young children with vertically acquired HIV infection, despite treatment. Substantial inter-individual differences in change were however observed. Factors which explained part of the variance in the magnitude and direction of change were baseline structural and functional abnormalities, rating of degree of CNS penetration of the drug protocol, and concurrent changes on other variables. These preliminary data suggest that CNS specific effects of therapies as well as pretreatment status of CNS function/structure need to be taken into consideration when evaluating future trials of anti-retroviral therapy for children with symptomatic HIV infection.

View details for Web of Science ID A1994PP10900011

View details for PubMedID 7874390